Carregant...
Oncolytic Adenovirus Retargeted to Delta-EGFR Induces Selective Antiglioma Activity
The fact that glioblastomas, which are one of the most devastating cancers, frequently express the Delta EGFR also called mutant variant III of EGFR (EGFRvIII) suggests that this cancer cell–specific receptor might serve as an ideal target for cancer therapy. To assess its potential as such a target...
Guardat en:
| Autors principals: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3793894/ https://ncbi.nlm.nih.gov/pubmed/18927600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cgt.2008.75 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|